187 results on '"Albanese, Alberto"'
Search Results
2. Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect
3. Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
4. Post-COVID parkinsonism: A scoping review
5. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
6. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
7. Dystonic Tremor
8. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
9. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
10. Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?
11. Causality or hazard in post-COVID parkinsonism?
12. Dystonic Tremor: Time to Change
13. Benefit of Repeated Injections of IncobotulinumtoxinA for Pain Reduction in Adults with Cervical Dystonia and Moderate or Severe Baseline Pain: An Analysis of Pooled Data (P8-3.004)
14. Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: Sub-analysis of Cervical Dystonia Patients (P1-3.018)
15. 1137 Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: A Sub-analysis of Cervical Dystonia Patients
16. Eligibility criteria in clinical trials for cervical dystonia
17. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
18. Development of a patient journey map for people living with cervical dystonia
19. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
20. The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping Review.
21. Functional motor phenotypes: to lump or to split?
22. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
23. Does sex influence the natural history of idiopathic adult-onset dystonia?
24. Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
25. Pain Reduction in Adults With Cervical Dystonia Following a Single Injection of IncobotulinumtoxinA: A Pooled Analysis
26. Pain Reduction After Repeated Injections of IncobotulinumtoxinA for Pain Reduction in Adults With Cervical Dystonia and Moderate or Severe Baseline Pain
27. Duration of Botulinum Toxin Efficacy in Cervical Dystonia Clinical Trials: A Narrative Review
28. Benefit of Multiple IncobotulinumtoxinA Injections for Pain Reduction in Adults With Cervical Dystonia: An Analysis of Pooled Data
29. The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes
30. Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.
31. MRI abnormalities identify Neuronal Intranuclear Inclusion Disease (NIID)
32. Pain reduction in adults with cervical dystonia following a single injection of incobotulinumtoxina: A pooled analysis
33. Benefit of repeated injections of incobotulinumtoxina for pain reduction in adults with cervical dystonia and moderate or severe baseline pain: An analysis of pooled data
34. Benefit of multiple incobotulinumtoxina injections for pain reduction in adults with cervical dystonia: An analysis of pooled data
35. Elderly Onset of Functional Motor Disorders: Clinical Correlates from the Italian Registry
36. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
37. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
38. Case report: Atypical Parkinsonism following SARS-CoV-2 infection
39. Phenotypic Variability in Acquired and Idiopathic Dystonia
40. Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
41. Improvement in Cervical Dystonia – Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation (DBS) (P11-11.002)
42. Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
43. Dystonia as presenting feature of compound heterozygous PMPCA gene variants
44. Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study.
45. Functional movement disorder gender, age and phenotype study
46. Isolated Cervical Dystonia: Diagnosis and Classification
47. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
48. Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease
49. Data-driven clustering of combined Functional Motor Disorders based on the Italian registry
50. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.